Table of Contents
Chapter 1. Global Anthelmintic Drugs Market Executive Summary
1.1. Global Anthelmintic Drugs Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Drug Class
1.3.2. By Infection Type
1.3.3. By Distribution Channel
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Anthelmintic Drugs Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer's Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory Frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Anthelmintic Drugs Market Dynamics
3.1. Market Drivers
3.1.1. Growing Prevalence of Helminth Infections
3.1.2. Increasing Awareness for Preventive Measures
3.1.3. Availability of Generic Drugs
3.2. Market Challenges
3.2.1. Affordability Issues in Low-Income Regions
3.2.2. Economic Downturns Impacting Healthcare Budgets
3.3. Market Opportunities
3.3.1. Research and Development in Drug Formulations
3.3.2. Expansion of Distribution Networks
3.3.3. Public Health Initiatives
Chapter 4. Global Anthelmintic Drugs Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model
4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top Investment Opportunity
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Anthelmintic Drugs Market Size & Forecasts by Drug Class 2022-2032
5.1. Segment Dashboard
5.2. Global Anthelmintic Drugs Market: Drug Class Revenue Trend Analysis, 2022 & 2032 (USD Billion)
5.2.1. Benzimidazoles
5.2.2. Macrocyclic Lactones
5.2.3. Pyrazinoisoquinolones
5.2.4. Tetrahydropyrimidines
5.2.5. Others
Chapter 6. Global Anthelmintic Drugs Market Size & Forecasts by Infection Type 2022-2032
6.1. Segment Dashboard
6.2. Global Anthelmintic Drugs Market: Infection Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
6.2.1. Cestode Infections
6.2.2. Nematode Infections
6.2.3. Trematode Infections
6.2.4. Mixed Infections
Chapter 7. Global Anthelmintic Drugs Market Size & Forecasts by Distribution Channel 2022-2032
7.1. Segment Dashboard
7.2. Global Anthelmintic Drugs Market: Distribution Channel Revenue Trend Analysis, 2022 & 2032 (USD Billion)
7.2.1. Online Providers
7.2.2. Hospital Pharmacies
7.2.3. Drug Stores and Retail Pharmacies
Chapter 8. Global Anthelmintic Drugs Market Size & Forecasts by Region 2022-2032
8.1. North America Anthelmintic Drugs Market
8.1.1. U.S. Anthelmintic Drugs Market
8.1.1.1. Drug Class breakdown size & forecasts, 2022-2032
8.1.1.2. Infection Type breakdown size & forecasts, 2022-2032
8.1.1.3. Distribution Channel breakdown size & forecasts, 2022-2032
8.1.2. Canada Anthelmintic Drugs Market
8.1.2.1. Drug Class breakdown size & forecasts, 2022-2032
8.1.2.2. Infection Type breakdown size & forecasts, 2022-2032
8.1.2.3. Distribution Channel breakdown size & forecasts, 2022-2032
8.2. Europe Anthelmintic Drugs Market
8.2.1. U.K. Anthelmintic Drugs Market
8.2.2. Germany Anthelmintic Drugs Market
8.2.3. France Anthelmintic Drugs Market
8.2.4. Spain Anthelmintic Drugs Market
8.2.5. Italy Anthelmintic Drugs Market
8.2.6. Rest of Europe Anthelmintic Drugs Market
8.3. Asia-Pacific Anthelmintic Drugs Market
8.3.1. China Anthelmintic Drugs Market
8.3.2. India Anthelmintic Drugs Market
8.3.3. Japan Anthelmintic Drugs Market
8.3.4. Australia Anthelmintic Drugs Market
8.3.5. South Korea Anthelmintic Drugs Market
8.3.6. Rest of Asia Pacific Anthelmintic Drugs Market
8.4. Latin America Anthelmintic Drugs Market
8.4.1. Brazil Anthelmintic Drugs Market
8.4.2. Mexico Anthelmintic Drugs Market
8.4.3. Rest of Latin America Anthelmintic Drugs Market
8.5. Middle East & Africa Anthelmintic Drugs Market
8.5.1. Saudi Arabia Anthelmintic Drugs Market
8.5.2. South Africa Anthelmintic Drugs Market
8.5.3. Rest of Middle East & Africa Anthelmintic Drugs Market
Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. GlaxoSmithKline plc
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Market Strategies
9.3.2. Johnson & Johnson
9.3.3. Merck & Co., Inc.
9.3.4. Bayer AG
9.3.5. Cipla Ltd.
9.3.6. Sun Pharmaceutical Industries Ltd.
9.3.7. Teva Pharmaceutical Industries Limited
9.3.8. Reese Pharmaceutical Company
9.3.9. Zydus Lifesciences Limited
9.3.10. Cadila Pharmaceuticals
9.3.11. Regulus
9.3.12. John Lee
9.3.13. Mediva
9.3.14. Intas Pharmaceuticals
9.3.15. Mankind Pharma Ltd
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes